| 1. | nellynat6 | |
| 2. | crofoothill | |
| 3. | aquarian450202 | |
| 4. | lsccbean | |
| 5. | mmcc3439 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | aquarian450202 02/21/2018 bull momentum |
| 2. | nellynat6 02/21/2018 What's happening today? |
| 3. | crofoothill 02/21/2018 Fate Therapeutics Announces First Subject Treated with FATE-NK100 in DIMENSION Study for Advanced Solid Tumors |
| 4. | crofoothill 05/11/2018 Fate Therapeutics Reports First Quarter 2018 Financial Results and Highlights Operational Progress |
| 5. | nellynat6 05/06/2018 Files for $150 mln mixed securities shelf offering |
| 6. | aquarian450202 02/26/2018 Fate Therapeutics Announces Receipt of CIRM Grant for Clinical Translation of FT516 Off-the-Shelf Engineered NK Cell Cancer Immunotherapy |
| 7. | lsccbean 02/21/2018 I'm in. |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Fate Therapeutics, Inc.
- FATE
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.